What Does BI-RADS 0 Mean With Fibrocystic Changes?

Seeing the word “incomplete” or a score of “BI-RADS 0” on your mammogram report can immediately spark anxiety, especially if you are worried about breast cancer. However, a BI-RADS 0 score is not a diagnosis of cancer; it simply means the radiologist does not have enough information to give you a final reading ^[1][2]. It indicates that your screening mammogram is inconclusive and that more imaging or information is needed to understand what was seen on the scan ^[1][2].

What the BI-RADS Numbers Mean

To understand your result, it helps to see how the Breast Imaging Reporting and Data System (BI-RADS) categorizes findings. After your diagnostic follow-up is complete, your radiologist will assign a final category:

• BI-RADS 0: Incomplete. Additional imaging or prior mammograms are needed.
• BI-RADS 1 & 2: Negative or Benign. Routine screening is recommended.
• BI-RADS 3: Probably Benign. A finding is present with a very low chance of cancer, usually managed with a short-interval follow-up scan (often in 6 months) to monitor for changes ^[3][4].
• BI-RADS 4 & 5: Suspicious or Highly Suspicious. An abnormality was found that requires further evaluation, generally a tissue biopsy ^[5][6].

Fibrocystic Changes vs. Breast Density

A BI-RADS 0 assessment can be assigned for many reasons, including an unexplained asymmetry, a possible mass, calcifications, technical issues with the scan, or missing prior images for comparison ^[2]. Two distinct but related factors can increase the likelihood of needing additional imaging:

1. Dense Breast Tissue: Mammograms are grayscale images. Dense breast tissue appears white on a mammogram ^[7]. Because tumors and non-cancerous findings also appear white, dense tissue can obscure or overlap with these areas, creating a “masking” effect that makes the images difficult to read clearly ^[8][9].
2. Fibrocystic Breast Changes: This is a broad, benign term commonly used for lumpy, tender, or cystic breast tissue ^[10]. While you may experience fibrocystic changes, this does not automatically mean you have dense breasts—they are separate medical factors, though both can independently influence your breast cancer risk and imaging needs ^[11][12].

When overlapping dense tissue or a benign cyst looks like a potential abnormality on a screening image, the radiologist will assign a BI-RADS 0 to pause the process and ask for more information ^[7][13].

What Happens Next?

Depending on your specific finding, age, and symptoms, your care team may recommend:

• Comparison to Prior Mammograms: If you had mammograms done at a different facility, the radiologist will want to compare your new images to the old ones. A suspected abnormality often turns out to be a stable, long-standing pattern that has not changed over time ^[2].
• Diagnostic Mammogram: This scan focuses on the specific area of concern. The technologist will take special, magnified, or localized compression views to spread the breast tissue out further, which can help resolve overlapping tissue shadows.
• Targeted Ultrasound: Ultrasound uses sound waves to evaluate a specific area. It is frequently used because it can often distinguish between a harmless, simple fluid-filled cyst and a solid mass ^[14]. However, complex cysts or solid masses may still require additional imaging or a biopsy to fully evaluate ^[13].

Your Next Steps

A BI-RADS 0 requires your attention, but it is not usually a medical emergency. You should contact your imaging center or clinician promptly to arrange the recommended diagnostic evaluation—do not wait for your next routine annual screening ^[1].

When you follow up, remember that supplemental screening (like a breast MRI or screening ultrasound) is highly individualized; having dense breasts or fibrocystic changes does not automatically mean you need advanced screening ^[15]. The decision should be based on your documented breast density, personal and family history, and genetic risk ^[7].

Finally, while fibrocystic breast pain is common, you should always alert your clinician if you notice new and concerning symptoms, such as a persistent hard lump, skin dimpling, nipple retraction, or unusual nipple discharge.